James River Church pastors David and Brandon Lindell appear on the Last in Line podcast to discuss their new book, Lionhearted, inspiring Christ-centered manhood
James River Church pastors David and Brandon Lindell appear on the Last in Line podcast to discuss their new book, Lionhearted, inspiring Christ-centered manhood
REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.
Alvotech (NASDAQ: ALVO) og samstarfsaðilar félagsins, Kashiv Biosciences og Advanz Pharma, kynntu í dag að jákvæð niðurstaða hefði náðst í klínískri rannsókn sem bar saman virkni AVT23, fyrirhugaðrar hliðstæðu líftæknilyfsins Xolair (omalizumab), og virkni frumlyfsins. Xolair er lyf sem gefið er við ofnæmisastma og fleiri skyldum sjúkdómum. Kashiv Biosciences er líftæknifyrirtæki með höfuðstöðvar í New Jersey í Bandaríkjunum. Advanz Pharma er alþjóðlegt lyfjafyrirtæki sem markaðssetur lyfseðilsskyld lyf, stungu- og innrennslislyf og lyf við sjaldgæfum sjúkdómum. Það er með höfuðstöðvar í Bretlandi.
SINGAPORE, June 25, 2025 /PRNewswire/ -- In a heartfelt tribute to Singapore's 60th birthday, Four Points by Sheraton Singapore, Riverview is proud to introduce an...
CHICAGO, June 24, 2025 /PRNewswire/ -- TTX Company announces with deep sorrow the passing of Raymond C. Burton, Jr., the company's former President and...
WOODLAND PARK, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) today announced fiscal 2025 fourth quarter and full fiscal year financial results and filed its 10-K for the year ended March 31, 2025. The Company also issued an update on its Demonstrated Intent metric which can be found on Anterix’s website at https://investors.anterix.com/events-presentations.
Over 390 students have completed the program nationwide since 2015FLORHAM PARK, N.J., June 24, 2025 /PRNewswire/ -- BASF is celebrating the 10th anniversary of...
SHANGHAI, June 24, 2025 /PRNewswire/ -- The 2025 Shanghai International Film & TV Market is making waves for its deeper industry innovations. For the...
SHENZHEN, China, June 23, 2025 /PRNewswire/ -- itel, a global leading smart life brand for everyone, proudly announced that its latest wireless earbuds, BudsNeo...